Is endoscopic ultrasound "sound" for pancreatic cancer screening?

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Clinical Gastroenterology

• Publication date

  2009-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MCG.0b013e3181b3ab58PMID 19652621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Investigating Population Risk Factors of Pancreatic Cancer by Evaluation of Optical Markers in the Duodenal Mucosa

  2009cited by this paper
• Atypical Familial Presentation of FAMMM Syndrome With a High Incidence of Pancreatic Cancer: Case Finding of Asymptomatic Individuals by EUS Surveillance

  2009cited by this paper
• Methylated genes as new cancer biomarkers.

  2009cited by this paper
• Methylated genes as new cancer biomarkers

  2009cited by this paper
• Interventional Endoscopic Ultrasound

  2009cited by this paper
• Genome-wide profiling at methylated promoters in pancreatic adenocarcinoma

  2008cited by this paper
• Digital image analysis of EUS images accurately differentiates pancreatic cancer from chronic pancreatitis and normal tissue.

  2008cited by this paper
• Preoperative evaluation of pancreatic adenocarcinoma.

  2008cited by this paper
• Long-term survival after pancreatoduodenectomy for ductal adenocarcinoma: the emperor has no clothes?

  2008cited by this paper
• Recent patents concerning diagnostic and therapeutic applications of aberrantly methylated sequences in pancreatic cancer.

  2008cited by this paper
• Current status of gene expression profiling of pancreatic cancer.

  2008cited by this paper
• Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature.

  2008cited by this paper
• Efficacy of Endoscopic Ultrasound in Characterizing Mass Lesions in Chronic Pancreatitis

  2008cited by this paper
• Pancreatic cancer: a review of the evidence on causation.

  2008cited by this paper
• Optical Markers in Duodenal Mucosa Predict the Presence of Pancreatic Cancer

  2007cited by this paper
• Pancreatic Tissue Characterization By Endoscopic Ultrasound (EUS) Spectrum Analysis

  2007cited by this paper
• Advances in counselling and surveillance of patients at risk for pancreatic cancer

  2007cited by this paper
• Detecting early pancreatic cancer: problems and prospects.

  2007influential reference
• A Clinical and Economic Evaluation of Endoscopic Ultrasound for Patients at Risk for Familial Pancreatic Adenocarcinoma

  2007cited by this paper
• Current therapies and advances in the treatment of pancreatic cancer.

  2006cited by this paper
• Pancreatic adenocarcinoma

  2006cited by this paper
• Raman spectroscopy: elucidation of biochemical changes in carcinogenesis of oesophagus

  2006cited by this paper
• DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.

  2006cited by this paper
• Evidence-based diagnosis and staging of pancreatic cancer.

  2006cited by this paper
• Interventional Endoscopic Ultrasound in Pancreatic Diseases

  2006cited by this paper
• Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review.

  2006cited by this paper
• Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.

  2006cited by this paper
• The inherited genetics of pancreatic cancer and prospects for secondary screening.

  2006cited by this paper
• Low efficacy of serum levels of CA 19-9 in prediction of malignant diseases in asymptomatic population in Taiwan.

  2006cited by this paper
• Epidemiology and risk factors for pancreatic cancer.

  2006cited by this paper
• Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis.

  2005cited by this paper
• Age- and disease-related methylation of multiple genes in nonneoplastic duodenum and in duodenal juice.

  2005cited by this paper
• Pancreatic FNA in 1000 cases: a comparison of imaging modalities.

  2005cited by this paper
• Diagnosing pancreatic malignancy in the setting of chronic pancreatitis: is there room for improvement?

  2005cited by this paper
• Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups.

  2005cited by this paper
• Ultrasonography, Computed Tomography and Magnetic Resonance Imaging for Diagnosis and Determining Resectability of Pancreatic Adenocarcinoma: A Meta-Analysis

  2005cited by this paper
• Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds

  2004cited by this paper
• Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.

  2004cited by this paper
• Four-dimensional elastic light-scattering fingerprints as preneoplastic markers in the rat model of colon carcinogenesis.

  2004cited by this paper
• Microarray-based gene expression profiling in pancreatic ductal carcinoma: status quo and perspectives

  2004cited by this paper
• Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment.

  2004cited by this paper
• Clinical usefulness of carbohydrate antigen 19‐9 as a screening test for pancreatic cancer in an asymptomatic population

  2004cited by this paper
• Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.

  2004cited by this paper
• Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays.

  2004cited by this paper
• Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer.

  2003cited by this paper
• Raman spectroscopy, a potential tool for the objective identification and classification of neoplasia in Barrett's oesophagus

  2003cited by this paper
• Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds.

  2003cited by this paper
• Prognostic Factors Following Curative Resection for Pancreatic Adenocarcinoma: A Population-Based, Linked Database Analysis of 396 Patients

  2003cited by this paper
• Diagnosing Pancreatic Cancer Using Methylation Specific PCR Analysis

  2003cited by this paper
• A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.

  2003cited by this paper
• Diagnosis, staging, and surveillance of pancreatic cancer.

  2003cited by this paper
• Interventional endoscopic ultrasound.

  2003cited by this paper
• How many millimeters do atypical epithelia of the pancreas spread intraductally before beginning to infiltrate?

  2003cited by this paper
• Differentiating pancreatic cancer from pseudotumorous chronic pancreatitis

  2002cited by this paper
• Comparison of endoscopic ultrasound-guided fine needle aspiration for focal pancreatic lesions in patients with normal parenchyma and chronic pancreatitis

  2002cited by this paper
• A prospective cohort study of cigarette smoking and pancreatic cancer in Japan

  2002cited by this paper
• Detecting K-ras and p53 gene mutation from stool and pancreatic juice for diagnosis of early pancreatic cancer.

  2002cited by this paper
• Molecular Diagnosis of Early Pancreatic Ductal Adenocarcinoma in High-Risk Patients

  2001cited by this paper
• Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer

  2001cited by this paper
• Inherited Pancreatic Cancer: Surveillance and Treatment Strategies for Affected Families

  2001cited by this paper
• Neural network analysis of EUS images to differentiate between pancreatic malignancy and pancreatitis.

  2001cited by this paper
• Multi--detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma.

  2001cited by this paper
• Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice

  2001cited by this paper
• Physical activity, obesity, height, and the risk of pancreatic cancer.

  2001cited by this paper
• Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer.

  2000cited by this paper
• Predictors of pancreatic cancer mortality among a large cohort of United States adults

  2000cited by this paper
• Early Diagnosis and Treatment of Pancreatic Dysplasia in Patients with a Family History of Pancreatic Cancer

  1999cited by this paper
• Interventional endoscopic ultrasonography: current status and future direction.

  1999cited by this paper
• K-ras mutations in tissue and stool samples from patients with pancreatic cancer and chronic pancreatitis

  1999cited by this paper
• Interventional endoscopic ultrasonography: current status and future direction.

  1999cited by this paper
• Minute carcinoma of the pancreas measuring 1 cm or less in diameter--collective review of Japanese case reports.

  1999cited by this paper
• Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography.

  1998cited by this paper
• Epidemiology of and risk factors for pancreatic cancer.

  1998cited by this paper
• CA 19-9 as a Marker for Gastrointestinal Cancers: A Review

  1998cited by this paper
• Prognostic value of CA 19-9 serum course in pancreatic cancer.

  1998cited by this paper
• Endoscopic ultrasound-guided fine-needle aspiration biopsy and interventional endoscopic ultrasonography. Emerging technologies.

  1997cited by this paper
• Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy.

  1996cited by this paper
• Common expression of the tumor marker D-galactose-beta-[1-->3]-N-acetyl-D-galactosamine by different adenocarcinomas: evidence of field effect phenomenon.

  1995cited by this paper
• Epidemiology of and risk factors for pancreatic cancer.

  1995cited by this paper
• Mortality in relation to smoking: 40 years' observations on male British doctors

  1994cited by this paper
• CA19‐9 as a Screening and Diagnostic Tool in Symptomatic Patients: The Japanese Experience

  1994cited by this paper
• The “Working Group”

  1994cited by this paper
• Reported family aggregation of pancreatic cancer within a population-based case-control study in the francophone community in Montreal, Canada

  1991cited by this paper
• The clinical utility of the CA 19-9 tumor-associated antigen.

  1990cited by this paper
• Tumor markers in pancreatic cancer--current concepts.

  1989cited by this paper
• Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer.

  1989cited by this paper
• Enzyme immunoassay of pancreatic oncofetal antigen (POA) as a marker of pancreatic cancer.

  1985cited by this paper
• Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin.

  1983cited by this paper
• Ultrasonic endoscope.

  1980cited by this paper
• ULTRASONIC ENDOSCOPE

  1980cited by this paper
• International Agency for Research on Cancer.

  1968cited by this paper

• Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a systematic review and meta-analysis

  2022cites this paper
• Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a systematic review and meta-analysis.

  2022cites this paper
• Use of Biomarkers and Imaging for Early Detection of Pancreatic Cancer

  2020cites this paper
• Pancreatic cancer screening

  2018cites this paper
• The role of endoscopic ultrasound in pancreatic cancer screening

  2016cites this paper
• Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer.

  2014cites this paper